Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #14,691 to #14,740.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Neoadjuvant chemotherapy [329 bytes]
  2. (hist) Namazi Hospital [329 bytes]
  3. (hist) Danderyds sjukhus [329 bytes]
  4. (hist) Stertorous [329 bytes]
  5. (hist) Medial pterygoid [329 bytes]
  6. (hist) Dehydratase [329 bytes]
  7. (hist) Glenoid fossa [329 bytes]
  8. (hist) Smell [329 bytes]
  9. (hist) PCBM [329 bytes]
  10. (hist) Oxyphil cell [329 bytes]
  11. (hist) Groin hernia [329 bytes]
  12. (hist) Cervical dysplasia staging [329 bytes]
  13. (hist) Lymphangioma echocardiography or ultrasound [329 bytes]
  14. (hist) Mammary ductal carcinoma screening [329 bytes]
  15. (hist) Mammary ductal carcinoma history and symptoms [329 bytes]
  16. (hist) Mammary ductal carcinoma physical examination [329 bytes]
  17. (hist) Mammary ductal carcinoma laboratory tests [329 bytes]
  18. (hist) Mammary ductal carcinoma CT [329 bytes]
  19. (hist) Mammary ductal carcinoma MRI [329 bytes]
  20. (hist) Mammary ductal carcinoma echocardiography or ultrasound [329 bytes]
  21. (hist) Mammary ductal carcinoma other imaging findings [329 bytes]
  22. (hist) Mammary ductal carcinoma other diagnostic studies [329 bytes]
  23. (hist) Mammary ductal carcinoma medical therapy [329 bytes]
  24. (hist) Mammary ductal carcinoma primary prevention [329 bytes]
  25. (hist) Mammary ductal carcinoma secondary prevention [329 bytes]
  26. (hist) Mammary ductal carcinoma cost-effectiveness of therapy [329 bytes]
  27. (hist) Mammary ductal carcinoma future or investigational therapies [329 bytes]
  28. (hist) Meningioma secondary prevention [329 bytes]
  29. (hist) Anemia risk factors [329 bytes]
  30. (hist) Lymphadenopathy cost-effectiveness of therapy [329 bytes]
  31. (hist) Complex regional pain syndrome cost-effectiveness of therapy [329 bytes]
  32. (hist) Microcephaly overview [329 bytes]
  33. (hist) Xerosis case study one [329 bytes]
  34. (hist) Xerosis future or investigational therapies [329 bytes]
  35. (hist) Xerosis cost-effectiveness of therapy [329 bytes]
  36. (hist) Xerosis natural history, complications and prognosis [329 bytes]
  37. (hist) Xerosis risk factors [329 bytes]
  38. (hist) Xerosis differential diagnosis [329 bytes]
  39. (hist) Xerosis pathophysiology [329 bytes]
  40. (hist) Xerosis classification [329 bytes]
  41. (hist) Xerosis historical perspective [329 bytes]
  42. (hist) Diabetic retinopathy laboratory findings [329 bytes]
  43. (hist) Hyperaldosteronism epidemiology and demographics [329 bytes]
  44. (hist) Cavernous sinus thrombosis primary prevention [329 bytes]
  45. (hist) Pancoast tumor case study one [329 bytes]
  46. (hist) Pancoast tumor cost-effectiveness of therapy [329 bytes]
  47. (hist) Pancoast tumor future or investigational therapies [329 bytes]
  48. (hist) Bronchiectasis cost-effectiveness of therapy [329 bytes]
  49. (hist) Bronchiectasis future or investigational therapies [329 bytes]
  50. (hist) Bronchiectasis here case study one [329 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ShortPages"